Sharp Brains: Brain Fitness and Cognitive Health News

Neuroplasticity, Brain Fitness and Cognitive Health News


Growing research aims at helping cancer patients in distress access most-likely-to-help self-care options, from Mindfulness training to Web-based cognitive behavioral therapy (CBT)

Cred­it: UCIrvine/flickr , CC BY-NC-ND


Mind­ful­ness in can­cer treat­ment: time to stop and think (The Con­ver­sa­tion):

Breathe deeply and focus on the moment: mind­ful­ness now appears every­where as a tech­nique to improve well-being, includ­ing in health care.

Mind­ful­ness train­ing is often sug­gest­ed for can­cer patients to reduce high lev­els of anx­i­ety and dis­tress asso­ci­at­ed with diag­no­sis, treat­ment and antic­i­pa­tion of pos­si­ble dis­ease recur­rence. But two ques­tions per­sist: does mind­ful­ness work and, if so, for whom? Read the rest of this entry »

Next: Tools to detect and treat “chemo brain” symptoms common in around 35% of breast cancer survivors

fog brainUCLA study reveals treat­ment for women with breast can­cer suf­fer­ing cog­ni­tive dif­fi­cul­ties (Health­Canal):

UCLA researchers have devel­oped a pro­gram that could improve the day-to-day lives of women with breast can­cer by address­ing post-treat­ment cog­ni­tive dif­fi­cul­ties, some­times known as “chemo brain,” which can affect up to 35 per­cent of women after their treat­ments Read the rest of this entry »

Why computerized neuropsychological tests will become routine — chemo brain example

Good arti­cle today in the NYT on “chemo brain” — some typ­i­cal short-term and long-term cog­ni­tive con­se­quences of chemother­a­py.

The Fog That Fol­lows Chemother­a­py (New York Times)

This quote is crit­i­cal — for chemo brain and also for a vari­ety of clin­i­cal con­di­tions that present asso­ci­at­ed cog­ni­tive impair­ments: “Con­trol­ling for brain func­tion before can­cer treat­ment begins can help deter­mine cause and effect. In one study, can­cer patients took a bat­tery of neu­ropsy­cho­log­i­cal tests before start­ing chemother­a­py, three weeks after com­plet­ing treat­ment, and again one year lat­er. Although a third of the patients had signs of cog­ni­tive impair­ment before ther­a­py began, the num­ber jumped to 61 per­cent after treat­ment, and half remained impaired a year lat­er.”

As we have dis­cussed before, we believe that inex­pen­sive com­put­er­ized cog­ni­tive assess­ments will start to become wide­ly avail­able in only a few years, to help set up indi­vid­u­al­ized cog­ni­tive base­lines and inform clin­i­cal diag­noses and treat­ments. For more, you can read Com­put­er­ized Cog­ni­tive Assess­ments: oppor­tu­ni­ties and con­cerns

About SharpBrains

As seen in The New York Times, The Wall Street Journal, BBC News, CNN, Reuters,  SharpBrains is an independent market research firm tracking how brain science can improve our health and our lives.

Search in our archives

Follow us and Engage via…

RSS Feed

Watch All Recordings Now (40+ Speakers, 12+ Hours)

Enter Your Email to receive Sharp­Brains free, monthly eNewslet­ter:

Join more than 50,000 Sub­scribers and stay informed and engaged.